Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.680
+0.100 (6.33%)
At close: Jun 26, 2026, 4:00 PM EDT
1.640
-0.040 (-2.38%)
After-hours: Jun 26, 2026, 6:58 PM EDT
Acrivon Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Jeff Jonas Gabelli No rating | Gabelli | Buy Initiates $8 | Buy | Initiates | $8 | +376.19% | Jun 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $8 | Buy | Initiates | $8 | +376.19% | Jun 15, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $7 | Buy | Reiterates | $7 | +316.67% | May 16, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $19 | Buy | Reiterates | $19 | +1,030.95% | May 14, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $14 | Buy | Maintains | $14 | +733.33% | Mar 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +376.19% | Mar 2, 2026 |